Jennifer Chan
Affiliations: | Pathology | Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States |
Google:
"Jennifer Chan"Bio:
BRIGHAM & WOMENS HOSPITAL
PATHOLOGY DEPT
75 FRANCIS ST 3RD FL ARMORY BL
BOSTON, MA 21156106
United States
Mean distance: 106866
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Perez K, Chan J. (2019) Treatment of Gastroenteropancreatic Neuroendocrine Tumors. Surgical Pathology Clinics. 12: 1045-1053 |
| Kulke MH, Benson AB, Dasari A, et al. (2019) Real-World Treatment Patterns and Clinical Outcomes in Advanced Gastrointestinal Neuroendocrine Tumors (GI NET): A Multicenter Retrospective Chart Review Study. The Oncologist |
| Shah MH, Goldner WS, Halfdanarson TR, et al. (2018) NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018. Journal of the National Comprehensive Cancer Network : Jnccn. 16: 693-702 |
| Urgoiti GR, Lawn S, Scott J, et al. (2015) Evaluation of p75 expression and patterns of recurrence in patients with malignant gliomas treated with bevacizumab. Journal of Clinical Oncology. 33 |
| Alshehri M, Ahn BY, Wang X, et al. (2015) Abstract A32: Cell autonomous and cell non-autonomous roles of p75 neurotrophin receptor (p75NTR) in glioma invasion Brain. 75 |
| Urgoiti GR, Lawn S, Scott J, et al. (2015) MTR-13EVALUATION OF p75 EXPRESSION AND PATTERNS OF RECURRENCE IN PATIENTS WITH MALIGNANT GLIOMAS TREATED WITH BEVACIZUMAB Neuro-Oncology. 17 |
| Chan J, Kulke M. (2014) Targeting the mTOR signaling pathway in neuroendocrine tumors. Current Treatment Options in Oncology. 15: 365-79 |
| Buczkowicz P, Hoeman C, Rakopoulos P, et al. (2014) Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations. Nature Genetics. 46: 451-6 |
| Lawn S, Dixit R, Chan J. (2014) Pm-08Investigating The Determinants Of Gbm Subtypes Using Novel Mouse Models Neuro-Oncology. 16 |
| Kenchappa R, Lawn S, Krishna N, et al. (2014) CS-14 * NEUROTROPHIN RECEPTORS TrkB AND TrkC ARE REQUIRED FOR SURVIVAL OF BRAIN TUMOR INITIATING CELLS Neuro-Oncology. 16: v54-v54 |